Gordon Baltuch, MD
Neurological Surgery · New York, NYNPI 1932144094
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Insightec,inc at 59.1% of the total. Reporting peaked in 2019 at $3,938 and has fallen 84.2% since, to $623 in 2025.
Across 82 payments — averaging $128.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insightec,inc$6K
- Medtronic$3K
- Boston Scientific$1K
- Abbott$360
- Neurocrine Biosciences, Inc.$25
Across 63 payments — averaging $19,595 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Insightec,ltd$716K
- Sumitomo Pharma America, Inc.$344K
- Sunovion Pharmaceuticals Inc.$89K
- Neurocrine Biosciences, Inc.$85K
What the payments were for
- Consulting fees$2,27522%
- Travel & lodging$3,23031%
- Food & beverage$5,01648%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insightec,inc | 42 | $6,215 |
| Medtronic(2 entities) | 13 | $2,913 |
| Boston Scientific | 17 | $1,008 |
| Abbott | 9 | $360 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Exablate$4,050
- PERCEPT PC BRAINSENSE$310
- GENERAL DBS$104
- INFINITY$100
How this compares
$10,521 in reported general payments places this provider in the 70th percentile of 446 neurological surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurological surgery in New York
- J MoccoNew York$1.6M
- Alejandro BerensteinNew York$1.1M
- Darryl LauNew York$915K
- Mark BilskyNew York$903K
- Jan-Karl BurkhardtNew York$441K
- Dean ChouNew York$383K
- Reade DeleacyNew York$329K
- Johanna FifiNew York$326K
- David LangerNew York$258K
- Ali BaajNew York$240K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.